Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Bjørn Stæhr Madsen, Jonel Trebicka, Maja Thiele, Mads Israelsen, Manimozhiyan Arumugan, Troels Havelund, Aleksander Krag

Journal title: Trials

Journal number: 19/1

Journal publisher: BioMed Central

Published year: 2018

DOI identifier: 10.1186/s13063-018-2523-9

ISSN: 1745-6215